FrancophonIA/ELRC3.0 huggingface dataset:
English: Other common side effects(may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Croatian: Druge česte nuspojave (mogu se pojaviti u do 1 na 10 osoba) uključuju promjene razina nekih krvnih stanica, cirkulirajućih masti u krvi te, u ranim fazama liječenja, privremena povećanja razine jetrenih enzima; povišene razine šećera u krvi i mokraći; povećanje razine mokraćne kiseline i kreatin fosfokinaze u krvi; pojačan apetit; omaglicu; nemir; nevoljno drhtanje; neuobičajene pokrete (diskinezije); zatvor; suha usta; osip; slabost; pojačan umor; zadržavanje vode u tijelu koje dovodi do oticanja ruku, zglobova ili stopala; vrućicu; bol u zglobovima te seksualne poremećaje kao što su smanjeni libido u muškaraca i žena ili erektilna disfunkcija u muškaraca.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains 10 mg olanzapine.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna bočica sadrži 10 mg olanzapina.
English: Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements(dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Croatian: Česte nuspojave (mogu se pojaviti u do 1 na 10 osoba) uključuju promjene razina nekih krvnih stanica, cirkulirajućih masti u krvi te, u ranim fazama liječenja, privremena povećanja razine jetrenih enzima; povišene razine šećera u krvi i mokraći; povećanje razine mokraćne kiseline i kreatin fosfokinaze u krvi; pojačan apetit; omaglicu; nemir; nevoljno drhtanje; neuobičajene pokrete (diskinezije); zatvor; suha usta; osip; slabost; pojačan umor; zadržavanje vode u tijelu koje dovodi do oticanja ruku, zglobova ili stopala; vrućicu; bol u zglobovima te seksualne poremećaje kao što su smanjeni libido u muškaraca i žena ili erektilna disfunkcija u muškaraca.
English: Sodium hydroxide.
Croatian: Sadrži laktozu hidrat.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 20 mg olanzapine
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna obložena tableta sadrži 20 mg olanzapina.
English: ZYPREXA 15 mg coated tablets Elliptical, blue, coated tablets debossed with “LILLY” and a numeric identicode “4415”.
Croatian: Eliptične, svijetlo plave, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4415”.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.
Croatian: 11. NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska.
English: In renally impaired patients (creatinine clearance < 10 ml/min) versus healthy subjects administered oral olanzapine, there was no significant difference in mean elimination half-life (37.7 versus 32.4 hr) or clearance (21.2 versus 25.0 l/hr).
Croatian: U bolesnika s oštećenjem bubrega (klirens kreatinina < 10 ml/min) koji su primili oralni olanzapin nije bilo značajne razlike u odnosu na zdrave ispitanike u prosječnom poluvremenu eliminacije (37,7
English: Excipient with known effect: Each coated tablet contains 312 mg lactose monohydrate.
Croatian: Pomoćna tvar s poznatim učinkom: Jedna obložena tableta sadrži 312 mg laktoze hidrata.
English: A vial of ZYPREXA can provide you with 10 mg of olanzapine.
Croatian: Jedna bočica lijeka ZYPREXA sadrži 10 mg olanzapina.
English: Hepatobiliary disorders Transient, asymptomatic elevations of hepatic aminotransferases (ALT, AST), especially in early treatment (see section
Croatian: Poremećaji jetre i žuči prolazni asimptomatski porasti razina aminotransferaza jetre (ALT, AST),
English: Renal and/or hepatic impairment
Croatian: Psihoza i/ili poremećaji ponašanja uzrokovani demencijom
English: INFORMATION IN BRAILLE ZYPREXA 10 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU ZYPREXA 10 mg
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 5 mg coated tablets olanzapine
Croatian: NAZIV LIJEKA ZYPREXA 5 mg obložene tablete olanzapin
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION ZYPREXA 10 mg olanzapine powder for solution for injection IM use
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA ZYPREXA 10 mg prašak za otopinu za injekciju i.m. primjena
English: Excipient with known effect: Each coated tablet contains 234 mg lactose monohydrate.
Croatian: Pomoćna tvar s poznatim učinkom: Jedna obložena tableta sadrži 234 mg laktoze hidrata.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 20 mg COATED TABLETS: BLISTER FOIL LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP ZYPREXA 20 mg OBLOŽENE
English: Discontinuation symptoms7, 12
Croatian: sindrom nemirnih nogu neuroleptički maligni sindrom (vidjeti dio 4.4)12 simptomi ustezanja7, 12
English: INFORMATION IN BRAILLE ZYPREXA 5 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU ZYPREXA 5 mg
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 2.5 mg COATED TABLETS: BLISTER FOIL LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP ZYPREXA 2,5 mg OBLOŽENE
English: The following table is based on the undesirable effects and laboratory investigations from clinical trials with ZYPREXA powder for solution for injection rather than oral olanzapine.
Croatian: ZYPREXA praška za otopinu za injekciju, a ne na ispitivanjima oralnog olanzapina.
English: Marketing Authorisation Holder Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 2.5 mg olanzapine
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna obložena tableta sadrži 2,5 mg olanzapina.
English: ZYPREXA 10 mg coated tablets
Croatian: ZYPREXA 10 mg obložene tablete
English: ZYPREXA 15 mg coated tablets are blue.
Croatian: ZYPREXA 15 mg obložene tablete su svjetloplave.
English: Excipient with known effect: Each coated tablet conatins 238 mg lactose monohydrate.
Croatian: Pomoćna tvar s poznatim učinkom: Jedna obložena tableta sadrži 238 mg laktoze hidrata.
English: In comparator studies of one year or less duration, olanzapine was associated with a statistically significant lower incidence of treatment emergent dyskinesia.
Croatian: olanzapin je bio povezan sa statistički značajno nižom incidencijom diskinezije koja se javlja s liječenjem.
English: ZYPREXA 20 mg coated tablets
Croatian: ZYPREXA 20 mg obložene tablete
English: Fluoxetine (a CYP2D6 inhibitor), single doses of antacid (aluminium, magnesium) or cimetidine have not been found to significantly affect the pharmacokinetics of olanzapine.
Croatian: Nije utvrđen značajan utjecaj fluoksetina (inhibitora CYP2D6), jednokratne doze antacida (aluminij,
English: MARKETING AUTHORISATION NUMBER (S) EU/1/96/022/016 Powder for solution for injection.
Croatian: EU/1/96/022/016 Prašak za otopinu za injekciju.
English: EU/1/96/022/011 - ZYPREXA - 7.5 mg - coated tablets - 28 tablets, per box.
Croatian: EU/1/96/022/011 - ZYPREXA - 7,5 mg - obložene tablete - 28 tableta po kutiji.
English: Changes in total fasting cholesterol levels from borderline at baseline (≥ 4.39 - < 5.17 mmol/l) to high (≥ 5.17 mmol/l) were very common.
Croatian: Vrlo česte su bile promjene ukupnih razina kolesterola natašte od graničnih početnih vrijednosti (≥ 4,39-< 5,17 mmol/l) do visokih vrijednosti
English: General disorders and administration site conditions Common (≥ 1/100 to < 1/10): Injection site discomfort.
Croatian: Često (≥ 1/100 i < 1/10): nelagoda na mjestu injekcije
English: PHARMACEUTICAL FORM AND CONTENTS Powder for solution for injection.
Croatian: OBLIK Prašak za otopinu za injekciju.
English: ZYPREXA 5 mg coated tablets
Croatian: ZYPREXA 5 mg obložene tablete
English: EU/1/96/022/006 - ZYPREXA - 7.5 mg - coated tablets - 56 tablets, per box.
Croatian: EU/1/96/022/006 - ZYPREXA - 7,5 mg - obložene tablete - 56 tableta po kutiji.
English: EU/1/96/022/037 - ZYPREXA - 7.5 mg - coated tablets - 98 tablets, per box.
Croatian: EU/1/96/022/037 - ZYPREXA - 7,5 mg - obložene tablete - 98 tableta po kutiji.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 10 mg olanzapine
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna obložena tableta sadrži 10 mg olanzapina.
English: EU/1/96/022/029 - ZYPREXA - 2.5 mg - coated tablets - 70 tablets, per box.
Croatian: EU/1/96/022/029 - ZYPREXA - 2,5 mg - obložene tablete - 70 tableta po kutiji.
English: Тел ; + 359 2 491 41 40
Croatian: ТП "Ели Лили Недерланд" Б.В. - България Тел: + 359 2 491 41 40
English: EU/1/96/022/031 - ZYPREXA - 7.5 mg - coated tablets - 70 tablets, per box.
Croatian: EU/1/96/022/031 - ZYPREXA - 7,5 mg - obložene tablete - 70 tableta po kutiji.
English: EU/1/96/022/033 - ZYPREXA - 15 mg - coated tablets - 70 tablets, per box.
Croatian: EU/1/96/022/033 - ZYPREXA - 15 mg - obložene tablete - 70 tableta po kutiji.
English: EU/1/96/022/034 - ZYPREXA - 20 mg - coated tablets - 70 tablets, per box.
Croatian: EU/1/96/022/034 - ZYPREXA - 20 mg - obložene tablete - 70 tableta po kutiji.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 15 mg COATED TABLETS: BLISTER FOIL LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP ZYPREXA 15 mg OBLOŽENE
English: Gastrointestinal disorders Mild, transient anticholinergic effects including constipation and
Croatian: Poremećaji probavnog sustava blagi, prolazni antikolinergički učinci uključujući konstipaciju i suhoću usta distenzija abdomena9
English: EU/1/96/022/009 - ZYPREXA - 10 mg - coated tablets - 28 tablets, per box.
Croatian: EU/1/96/022/009 - ZYPREXA - 10 mg - obložene tablete - 28 tableta po kutiji.
English: EU/1/96/022/035 - ZYPREXA - 2.5 mg - coated tablets - 98 tablets, per box.
Croatian: EU/1/96/022/035 - ZYPREXA - 2,5 mg - obložene tablete - 98 tableta po kutiji.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 5 mg olanzapine
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna obložena tableta sadrži 5 mg olanzapina.
English: EU/1/96/022/023 - ZYPREXA - 2.5 mg - coated tablets - 35 tablets, per box.
Croatian: EU/1/96/022/023 - ZYPREXA - 2,5 mg - obložene tablete - 35 tableta po kutiji.
English: SPECIAL STORAGE CONDITIONS Do not store above 25º C. Store in original package in order to protect from light
Croatian: POSEBNE MJERE ČUVANJA Ne čuvati na temperaturi iznad 25ºC.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each coated tablet contains 15 mg olanzapine
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna obložena tableta sadrži 15 mg olanzapina.
English: EU/1/96/022/012 - ZYPREXA - 15 mg - coated tablets - 28 tablets, per box.
Croatian: EU/1/96/022/012 - ZYPREXA - 15 mg - obložene tablete - 28 tableta po kutiji.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 10 mg COATED TABLETS: BLISTER FOIL LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP ZYPREXA 10 mg OBLOŽENE
English: EU/1/96/022/025 - ZYPREXA - 7.5 mg - coated tablets - 35 tablets, per box.
Croatian: EU/1/96/022/025 - ZYPREXA - 7,5 mg - obložene tablete - 35 tableta po kutiji.
English: Photosensitivity reaction Alopecia
Croatian: Opći poremećaji i reakcije na mjestu primjene
English: EU/1/96/022/002 - ZYPREXA - 2.5 mg - coated tablets - 28 tablets, per box.
Croatian: EU/1/96/022/002 - ZYPREXA - 2,5 mg - obložene tablete - 28 tableta po kutiji.
English: EU/1/96/022/028 - ZYPREXA - 20 mg - coated tablets - 35 tablets, per box.
Croatian: EU/1/96/022/028 - ZYPREXA - 20 mg - obložene tablete - 35 tableta po kutiji.
English: EU/1/96/022/019 - ZYPREXA - 2.5 mg - coated tablets - 56 tablets, per box.
Croatian: EU/1/96/022/019 - ZYPREXA - 2,5 mg - obložene tablete - 56 tableta po kutiji.
English: EU/1/96/022/032 - ZYPREXA - 10 mg - coated tablets - 70 tablets, per box.
Croatian: EU/1/96/022/032 - ZYPREXA - 10 mg - obložene tablete - 70 tableta po kutiji.
English: EU/1/96/022/040 - ZYPREXA - 20 mg - coated tablets - 98 tablets, per box.
Croatian: EU/1/96/022/040 - ZYPREXA - 20 mg - obložene tablete - 98 tableta po kutiji.
English: EU/1/96/022/004 - ZYPREXA - 5 mg - coated tablets - 28 tablets, per box.
Croatian: EU/1/96/022/004 - ZYPREXA - 5 mg - obložene tablete - 28 tableta po kutiji.
English: Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Croatian: Poremećaji kože i potkožnog tkiva osip reakcija fotoosjetljivosti alopecija reakcija na lijek uz eozinofiliju i sistemske simptome (DRESS)
English: EU/1/96/022/014 - ZYPREXA - 20 mg - coated tablets - 28 tablets, per box.
Croatian: EU/1/96/022/014 - ZYPREXA - 20 mg - obložene tablete - 28 tableta po kutiji.
English: EU/1/96/022/027 - ZYPREXA - 15 mg - coated tablets - 35 tablets, per box.
Croatian: EU/1/96/022/027 - ZYPREXA - 15 mg - obložene tablete - 35 tableta po kutiji.
English: EU/1/96/022/038 - ZYPREXA - 10 mg - coated tablets - 98 tablets, per box.
Croatian: EU/1/96/022/038 - ZYPREXA - 10 mg - obložene tablete - 98 tableta po kutiji.
English: ZYPREXA 15 mg coated tablets
Croatian: ZYPREXA 15 mg obložene tablete
English: EU/1/96/022/030 - ZYPREXA - 5 mg - coated tablets - 70 tablets, per box.
Croatian: EU/1/96/022/030 - ZYPREXA - 5 mg - obložene tablete - 70 tableta po kutiji.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ZYPREXA 5 mg COATED TABLETS: BLISTER FOIL LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP ZYPREXA 5 mg OBLOŽENE
English: EU/1/96/022/022 - ZYPREXA - 20 mg - coated tablets - 56 tablets, per box.
Croatian: EU/1/96/022/022 - ZYPREXA - 20 mg - obložene tablete - 56 tableta po kutiji.
English: EU/1/96/022/039 - ZYPREXA - 15 mg - coated tablets - 98 tablets, per box.
Croatian: EU/1/96/022/039 - ZYPREXA - 15 mg - obložene tablete - 98 tableta po kutiji.
English: EU/1/96/022/024 - ZYPREXA - 5 mg - coated tablets - 35 tablets, per box.
Croatian: EU/1/96/022/024 - ZYPREXA - 5 mg - obložene tablete - 35 tableta po kutiji.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 10 mg olanzapine per vial
Croatian: SADRŽAJ PO TEŽINI, VOLUMENU ILI DOZNOJ JEDINICI LIJEKA
English: EU/1/96/022/026 - ZYPREXA - 10 mg - coated tablets - 35 tablets, per box.
Croatian: EU/1/96/022/026 - ZYPREXA - 10 mg - obložene tablete - 35 tableta po kutiji.
English: EU/1/96/022/021 - ZYPREXA - 15 mg - coated tablets - 56 tablets, per box.
Croatian: EU/1/96/022/021 - ZYPREXA - 15 mg - obložene tablete - 56 tableta po kutiji.
English: ZYPREXA 10 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4117”.
Croatian: Okrugle, bijele, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4117”.
English: EU/1/96/022/036 - ZYPREXA - 5 mg - coated tablets - 98 tablets, per box.
Croatian: EU/1/96/022/036 - ZYPREXA - 5 mg - obložene tablete - 98 tableta po kutiji.
English: Eli Lilly Nederland B.V. Tel: + 31 (0)30 6025800
Croatian: Eli Lilly farmacevtska družba, d.o.o. Tel: + 386 (0) 1 580 00 10
English: EU/1/96/022/010 - ZYPREXA - 10 mg - coated tablets - 56 tablets, per box.
Croatian: EU/1/96/022/010 - ZYPREXA - 10 mg - obložene tablete - 56 tableta po kutiji.
English: (being sick) or usage of diuretics (water tablets)
Croatian: (Perforacija koja omogućuje odvajanje informacija za zdravstvene radnike)
English: EU/1/96/022/004 28 coated tablets EU/1/96/022/024 35 coated tablets EU/1/96/022/020 56 coated tablets EU/1/96/022/030 70 coated tablets EU/1/96/022/036 98 coated tablets
Croatian: EU/1/96/022/004 28 obloženih tableta EU/1/96/022/024 35 obloženih tableta EU/1/96/022/020 56 obloženih tableta EU/1/96/022/030 70 obloženih tableta EU/1/96/022/036 98 obloženih tableta
English: EU/1/96/022/020 - ZYPREXA - 5 mg - coated tablets - 56 tablets, per box.
Croatian: EU/1/96/022/020 - ZYPREXA - 5 mg - obložene tablete - 56 tableta po kutiji.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 7.5 mg coated tablets Olanzapine
Croatian: ZYPREXA 7,5 mg obložene tablete olanzapin
English: EU/1/96/022/01128 coated tablets EU/1/96/022/025 35 coated tablets EU/1/96/022/006 56 coated tablets EU/1/96/022/031 70 coated tablets EU/1/96/022/037 98 coated tablets
Croatian: EU/1/96/022/011 28 obloženih tableta EU/1/96/022/025 35 obloženih tableta EU/1/96/022/006 56 obloženih tableta EU/1/96/022/031 70 obloženih tableta EU/1/96/022/037 98 obloženih tableta
English: EU/1/96/022/012 28 coated tablets EU/1/96/022/027 35 coated tablets EU/1/96/022/021 56 coated tablets EU/1/96/022/033 70 coated tablets EU/1/96/022/039 98 coated tablets
Croatian: EU/1/96/022/012 28 obloženih tableta EU/1/96/022/027 35 obloženih tableta EU/1/96/022/021 56 obloženih tableta EU/1/96/022/033 70 obloženih tableta EU/1/96/022/039 98 obloženih tableta
English: EU/1/96/022/009 28 coated tablets EU/1/96/022/026 35 coated tablets EU/1/96/022/010 56 coated tablets EU/1/96/022/032 70 coated tablets EU/1/96/022/038 98 coated tablets
Croatian: EU/1/96/022/009 28 obloženih tableta EU/1/96/022/026 35 obloženih tableta EU/1/96/022/010 56 obloženih tableta EU/1/96/022/032 70 obloženih tableta EU/1/96/022/038 98 obloženih tableta
English: EU/1/96/022/002 28 coated tablets EU/1/96/022/023 35 coated tablets EU/1/96/022/019 56 coated tablets EU/1/96/022/029 70 coated tablets EU/1/96/022/035 98 coated tablets
Croatian: EU/1/96/022/002 28 obloženih tableta EU/1/96/022/023 35 obloženih tableta EU/1/96/022/019 56 obloženih tableta EU/1/96/022/029 70 obloženih tableta EU/1/96/022/035 98 obloženih tableta
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 2.5 mg coated tablets Olanzapine
Croatian: ZYPREXA 2,5 mg obložene tablete olanzapin
English: EU/1/96/022/014 28 coated tablets EU/1/96/022/028 35 coated tablets EU/1/96/022/022 56 coated tablets EU/1/96/022/034 70 coated tablets EU/1/96/022/040 98 coated tablets
Croatian: EU/1/96/022/014 28 tableta EU/1/96/022/028 35 tableta EU/1/96/022/022 56 tableta EU/1/96/022/034 70 tableta EU/1/96/022/040 98 tableta
English: Eli Lilly Italia S.p.A. Tel: + 39 055 42571
Croatian: Tel: + 39 055 42571
English: 1 vial EU/1/96/022/017 - ZYPREXA - Powder for solution for injection.
Croatian: 1 bočica EU/1/96/022/017 - ZYPREXA
English: ZYPREXA 5 mg coated tablets Round, white, coated tablets imprinted with “LILLY” and a numeric identicode “4115”.
Croatian: Okrugle, bijele, obložene tablete s otisnutom oznakom “LILLY” i brojčanom identifikacijskom oznakom “4115”.
English: Each coated tablet contains 7.5 mg olanzapine.
Croatian: ZYPREXA 7,5 mg obložene tablete Jedna obložena tableta sadrži 7,5 mg olanzapina.
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 10 mg coated tablets Olanzapine
Croatian: ZYPREXA 10 mg obložene tablete olanzapin
English: Management
Croatian: PRIMJENU
English: NAME OF THE MEDICINAL PRODUCT ZYPREXA 20 mg coated tablets olanzapine
Croatian: ZYPREXA 20 mg obložene tablete olanzapin
English: Do not take ZYPREXA
Croatian: ZYPREXA.
English: Only take other medicines while you are on ZYPREXA if your doctor tells you that you can. You might feel drowsy if ZYPREXA is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).
Croatian: Ako uzimate lijek ZYPREXA u kombinaciji s antidepresivima, lijekovima za tjeskobu ili lijekovima koji
English: See also information under the heading “Do not take Ifirmasta”.
Croatian: Vidjeti također informacije pod naslovom “Nemojte uzimati Ifirmastu”.
English: You can take Ifirmasta with or without food.
Croatian: Ifirmastu možete uzeti s hranom ili bez nje.
English: Ifirmasta should not be given to children under 18 years of age.
Croatian: Ifirmasta se ne smije davati djeci mlađoj od 18 godina.
English: PVC/PE/PVDC/Alu
Croatian: PVC/PE/PVDC/Al
English: However the terminal halflife was not significantly altered.
Croatian: Međutim, terminalni poluvijek nije bio značajno promijenjen.
English: It is important that you continue to take Ifirmasta until your doctor tells you otherwise.
Croatian: Važno je da nastavite uzimati Ifirmastu sve dok Vam liječnik ne kaže drugačije.
English: What Ifirmasta is and what it is used for
Croatian: Što je Ifirmasta i za što se koristi
English: This medicine should not be used in children and adolescents (< 18 years) because the safety and efficacy have not yet been fully established.
Croatian: Ovaj lijek ne smiju uzimati djeca ni adolescenti (< 18 godina) jer sigurnost i djelotvornost lijeka nisu još u potpunosti utvrđene.
English: The expiry date refers to the last day of that month.
Croatian: Rok valjanosti odnosi se na zadnji dan tog mjeseca.
English: The safety and efficacy of Ifirmasta in children aged 0 to 18 has not been established.
Croatian: Sigurnost i djelotvornost lijeka Ifirmasta u djece u dobi od 0 do 18 godina nisu ustanovljene.
English: - Patients with high blood pressure
Croatian: - Bolesnici s visokim krvnim tlakom
English: If you forget to take Ifirmasta
Croatian: Ako ste zaboravili uzeti Ifirmastu
English: White, oval tablets.
Croatian: Bijele, ovalne tablete.
English: Date of first authorisation: 1 December 2008 Date of latest renewal: 26 August 2013
Croatian: Datum posljednje obnove: 26. kolovoza 2013.
English: If you accidentally miss a daily dose, just take the next dose as normal.
Croatian: Ako slučajno zaboravite uzeti dnevnu dozu, uzmite sljedeću dozu kao i obično.
English: What Ifirmasta contains - The active substance is irbesartan.
Croatian: Što Ifirmasta sadrži - Djelatna tvar je irbesartan.
English: Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water).
Croatian: Progutajte tablete s dovoljnom količinom tekućine (npr. jedna čaša vode).
English: What you need to know before you take Ifirmasta
Croatian: Što morate znati prije nego počnete uzimati Ifirmastu
English: Other medicines and Ifirmasta
Croatian: Drugi lijekovi i Ifirmasta
English: hepatitis, abnormal liver function
Croatian: hepatitis, abnormalna funkcija jetre
English: Your doctor will normally advise you to stop taking Ifirmasta before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Ifirmasta.
Croatian: Liječnik će Vam obično preporučiti da prestanete uzimati Ifirmastu prije nego što zatrudnite ili čim saznate da ste trudni te će Vam savjetovati uzimanje drugog lijeka umjesto Ifirmaste.
English: No specific information is available on the treatment of overdosage with Ifirmasta.
Croatian: Nema dostupnih specifičnih podataka o liječenju predoziranja Ifirmastom.
English: Less than 2% of the dose is excreted in the urine as unchanged irbesartan.
Croatian: Manje od 2% doze izlučuje se urinom u obliku nepromijenjenog irbesartana.
English: What Ifirmasta is and what it is used for What you need to know before you take Ifirmasta How to take Ifirmasta
Croatian: Što se nalazi u ovoj uputi Što je Ifirmasta i za što se koristi Što morate znati prije nego počnete uzimati Ifirmastu Kako uzimati Ifirmastu
English: Therefore, the use of Ifirmasta is not recommended.
Croatian: Stoga se ne preporučuje primjena Ifirmaste.
English: After oral administration, irbesartan is well absorbed: studies of absolute bioavailability gave values of approximately 60-80%.
Croatian: Nakon peroralne primjene irbesartan se dobro apsorbira: ispitivanja apsolutne bioraspoloživosti pokazala su vrijednosti oko 60-80%.